Murine B7-H3 is a negative regulator of T cells
Open accessAbstract
T cell activation is regulated by the innate immune system through positive and negative costimulatory molecules. B7-H3 is a novel B7-like molecule with a putative receptor on activated T cells. Human B7-H3 was first described as a positive costimulator, most potently inducing IFN-gamma production and cellular immunity. In this study we examined the expression and function of mouse B7-H3. B7-H3 is mostly expressed on professional APCs; its expression on dendritic cells appears to be up-regulated by LPS. In contrast to human B7-H3, we found that mouse B7-H3 protein inhibited T cell activation and effector cytokine production. An antagonistic mAb to B7-H3 enhanced T cell proliferation in vitro and led to exacerbated experimental autoimmune encephalomyelitis in vivo. Therefore, mouse B7-H3 serves as a negative regulator of T cell activation and function.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CD276 (B7-H3) was expressed most prominently on CAFs and TSKs.
“Interestingly, CD276 (B7-H3), known to augment Tregs and inhibit T cell responses (Costa et al., 2018, Prasad et al., 2004, Suh et al., 2003), was expressed most prominently on CAFs and TSKs.”
From Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma (2020) · cites this paper as Prasad et al., 2004
The citation is attached to the description of B7-H3’s immune effects, not to the citing authors’ observation about CAFs and TSKs. The Discussion reports that murine B7-H3 reduces T-cell proliferation and IL-2 production, supporting inhibition of T-cell responses. The cited paper does not establish that B7-H3 augments Tregs. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · see citing works
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294 · see citing works
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749 · see citing works
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · see citing works
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496 · see citing works
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868 · see citing works
Sharpe, A. H., & Freeman, G. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri727 · Cited by 1,713 · see citing works
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A. (1999) · Nature · doi:10.1038/16717 · Cited by 1,482 · see citing works
Antigen Recognition By Class-I Restricted T Lymphocyte
Townsend, A., & Bodmer, H. C. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.003125 · Cited by 1,192 · see citing works
Linsley, P. S., Brady, W., Grosmaire, L. S., Aruffo, A. A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.3.721 · Cited by 1,126 · see citing works
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
Chapoval, A. I., Ni, J., Lau, J. S., Wilcox, R. A., Flies, D. B., Liu, D., Dong, H., Sica, G., Zhu, G., Tamada, K., et al. (2001) · Nature Immunology · doi:10.1038/85339 · Cited by 1,016 · see citing works
ICOS co-stimulatory receptor is essential for T-cell activation and function
Dong, C., Juedes, A. E., Temann, U.-A., Shresta, S., Allison, J. P., Ruddle, N. H., & Flavell, R. A. (2001) · Nature · doi:10.1038/35051100 · Cited by 936 · see citing works
Schwartz, R. H. (1985) · Annual Review of Immunology · doi:10.1146/annurev.iy.03.040185.001321 · Cited by 934 · see citing works
Carreno, B. M., & Collins, M. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091101.091806 · Cited by 895 · see citing works
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883 · see citing works
Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., & Honjo, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231486598 · Cited by 849 · see citing works
T-cell co-stimulation through B7RP-1 and ICOS
Yoshinaga, S. K., Whoriskey, J. S., Khare, S. D., Sarmiento, U. M., Guo, J., Horan, T., Shih, G. C., Zhang, M., Coccia, M. A., Kohno, T., et al. (1999) · Nature · doi:10.1038/45582 · Cited by 775 · see citing works
B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity
Sica, G., Choi, I.-H., Zhu, G., Tamada, K., Wang, S.-D., Tamura, H., Chapoval, A. I., Flies, D. B., Bajorath, J., & Chen, L. (2003) · Immunity · doi:10.1016/s1074-7613(03)00152-3 · Cited by 709 · see citing works
Molecular Basis of T Cell Inactivation by CTLA-4
Lee, K.-M., Chuang, E., Griffin, M., Khattri, R., Hong, D. K., Zhang, W., Straus, D., Samelson, L. E., Thompson, C. B., & Bluestone, J. A. (1998) · Science · doi:10.1126/science.282.5397.2263 · Cited by 684 · see citing works
ICOS is essential for effective T-helper-cell responses
Tafuri, A., Shahinian, A., Bladt, F., Yoshinaga, S. K., Jordana, M., Wakeham, A. C., Boucher, L.-M., Bouchard, D., Chan, V. S. F., Duncan, G. S., et al. (2001) · Nature · doi:10.1038/35051113 · Cited by 674 · see citing works
ICOS is critical for CD40-mediated antibody class switching
McAdam, A. J., Greenwald, R. J., Levin, M. A., Chernova, T., Malenkovich, N., Ling, V., Freeman, G. J., & Sharpe, A. H. (2001) · Nature · doi:10.1038/35051107 · Cited by 644 · see citing works
The Emerging Role of CTLA-4 as an Immune Attenuator
Thompson, C. B., & Allison, J. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80366-0 · Cited by 633 · see citing works
The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses
Suh, W.-K., Gajewska, B. U., Okada, H., Gronski, M. A., Bertram, E. M., Dawicki, W., Duncan, G. S., Bukczynski, J., Plyte, S., Elia, A., et al. (2003) · Nature Immunology · doi:10.1038/ni967 · Cited by 576 · see citing works
Transcriptional regulation of the IL-2 gene
Jain, J. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80107-3 · Cited by 568 · see citing works
B7h, a Novel Costimulatory Homolog of B7.1 and B7.2, Is Induced by TNFα
Swallow, M. M., Wallin, J. J., & Sha, W. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80117-x · Cited by 453 · see citing works
B7S1, a Novel B7 Family Member that Negatively Regulates T Cell Activation
Prasad, D. V. R., Richards, S., Muoi, X., & Dong, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00147-x · Cited by 431 · see citing works
B7x: A widely expressed B7 family member that inhibits T cell activation
Zang, X., Loke, P., Kim, J., MURPHY, K. M. M., Waitz, R., & Allison, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1434299100 · Cited by 401 · see citing works
Costimulatory regulation of T cell function
Chambers, C. A., & Allison, J. P. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80027-1 · Cited by 376 · see citing works
JNK is required for effector T-cell function but not for T-cell activation
Dong, C., Yang, D. D., Tournier, C., Whitmarsh, A. J., Xu, J., Davis, R. J., & Flavell, R. A. (2000) · Nature · doi:10.1038/35011091 · Cited by 328 · see citing works
Activation and inhibition of lymphocytes by costimulation
Frauwirth, K. A., & Thompson, C. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14941 · Cited by 326 · see citing works
Characterization of Mouse and Human B7-H3 Genes
Sun, M., Richards, S., Prasad, D. V. R., Mai, X. M., Rudensky, A. Y., & Dong, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6294 · Cited by 295 · see citing works
Activation and inhibition of lymphocytes by costimulation
Frauwirth, K. A., & Thompson, C. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214941 · Cited by 284 · see citing works
Accessory Molecule and Costimulation Requirements for CD4 T Cell Response
Croft, M., & Dubey, C. (1997) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v17.i1.40 · Cited by 227 · see citing works
Dabbagh, K., Dahl, M. E., Stepick‐Biek, P., & Lewis, D. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4524 · Cited by 212 · see citing works
Cutting Edge: Critical Role of Inducible Costimulator in Germinal Center Reactions
Dong, C., Temann, U.-A., & Flavell, R. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3659 · Cited by 210 · see citing works
Ling, V., Wu, P. W., Spaulding, V., Kieleczawa, J., Luxenberg, D. P., Carreno, B. M., & Collins, M. A. (2003) · Genomics · doi:10.1016/s0888-7543(03)00126-5 · Cited by 174 · see citing works
Transcriptional Regulation of Th2 Differentiation by Inducible Costimulator
Nurieva, R., Duong, J., Kishikawa, H., Dianzani, U., Rojo, J. M., Ho, I., Flavell, R. A., & Dong, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00144-4 · Cited by 148 · see citing works
Kubagawa, H., Chen, C., Ho, L. H., Shimada, T., Gartland, L., Mashburn, C. B., Uehara, T., Ravetch, J. V., & Cooper, M. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.309 · Cited by 148 · see citing works
Mouse B7-H3 induces antitumor immunity
Sun, X., Vale, M., Leung, E. Y., Kanwar, J. R., Gupta, R., & Krissansen, G. W. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302070 · Cited by 132 · see citing works
Regulation of immune and autoimmune responses by ICOS
Dong, C., & Nurieva, R. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00119-7 · Cited by 93 · see citing works
Liang, L., Porter, E. M., & Sha, W. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020298 · Cited by 84 · see citing works
Zhou, X., Yashiro–Ohtani, Y., Nakahira, M., Park, W. R., Abe, R., Hamaoka, T., Naramura, M., Gu, H., & Fujiwara, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3847 · Cited by 50 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Ji, A. L., Rubin, A. J., Thrane, K., Jiang, S., Reynolds, D. L., Meyers, R. M., Guo, M. G., George, B. M., Mollbrink, A., Bergenstråhle, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.039 · Cited by 1,117 · see citing works
“Interestingly, CD276 (B7-H3), known to augment Tregs and inhibit T cell responses (Costa et al., 2018; Prasad et al., 2004; Suh et al., 2003), was expressed most prominently on CAFs and TSKs.”
BackgroundNovel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Qin, S., Xu, L., Yi, M., Yu, S., Wu, K., & Luo, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1091-2 · Cited by 1,145 · see citing works
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Picarda, E., Ohaegbulam, K. C., & Zang, X. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2428 · Cited by 582 · see citing works
Interleukin 25 promotes the initiation of proallergic type 2 responses
Angkasekwinai, P., Park, H., Wang, Y., Wang, Y., Chang, S. H., Corry, D. B., Liu, Y.-J., Zhu, Z., & Dong, C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061675 · Cited by 553 · see citing works
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Schildberg, F. A., Klein, S. R., Freeman, G. J., & Sharpe, A. H. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.002 · Cited by 537 · see citing works
Senescence-Associated Exosome Release from Human Prostate Cancer Cells
Lehmann, B. D., Paine, M. S., Brooks, A. M., McCubrey, J. A., Renegar, R. H., Wang, R., & Terrian, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6538 · Cited by 464 · see citing works
Du, H., Hirabayashi, K., Ahn, S., Kren, N. P., Montgomery, S. A., Wang, X., Tiruthani, K., Mirlekar, B., Michaud, D. E., Greene, K. G., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.002 · Cited by 480 · see citing works
Zang, X., Thompson, R. H., Al-Ahmadie, H. A., Serio, A. M., Reuter, V. E., Eastham, J. A., Scardino, P. T., Sharma, P., & Allison, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709802104 · Cited by 401 · see citing works
B7-H3: An Attractive Target for Antibody-based Immunotherapy
Kontos, F., Michelakos, T. P., Kurokawa, T., Sadagopan, A., Schwab, J. H., Ferrone, C. R., & Ferrone, S. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2584 · Cited by 399 · see citing works
Cancer prevention and therapy through the modulation of the tumor microenvironment
Casey, S. C., Amedei, A., Aquilano, K., Azmi, A. S., Benencia, F., Bhakta-Guha, D., Bilsland, A. E., Boosani, C. S., Chen, S., Ciriolo, M. R., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.007 · Cited by 373 · see citing works
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
Zang, X., & Allison, J. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1030 · Cited by 335 · see citing works
Lee, Y.-H., Martin-Orozco, N., Zheng, P., Li, J., Zhang, P., Tan, H., Park, H. J., Jeong, M., Chang, S. H., Kim, B.-S., et al. (2017) · Cell Research · doi:10.1038/cr.2017.90 · Cited by 328 · see citing works
Self-citationThe B7 family of immune-regulatory ligands.
Collins, M. A., Ling, V., & Carreno, B. M. (2005) · Genome biology · doi:10.1186/gb-2005-6-6-223 · Cited by 318 · see citing works
Emerging targets in cancer immunotherapy
Burugu, S., Dancsok, A. R., & Nielsen, T. O. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.001 · Cited by 316 · see citing works
B7-H3 and B7-H4 expression in non-small-cell lung cancer
Sun, Y., Wang, Y., Zhao, J., Gu, M., Giscombe, R., Lefvert, A. K., & Wang, X. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.05.012 · Cited by 313 · see citing works
CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance
Wang, C., Li, Y., Jia, L., Kim, J. K., Li, J., Deng, P., Zhang, W., Krebsbach, P. H., & Wang, C. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.04.011 · Cited by 314 · see citing works
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Zhang, Q., & Vignali, D. A. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.017 · Cited by 299 · see citing works
B7-H3/CD276: An Emerging Cancer Immunotherapy
Zhou, W.-T., & Jin, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701006 · Cited by 295 · see citing works
B7‐H3 is a potent inhibitor of human T‐cell activation: No evidence for B7‐H3 and TREML2 interaction
Leitner, J. M., Klauser, C., Pickl, W. F., Stöckl, J., Majdic, O., Bardet, A. F., Kreil, D. P., Dong, C., Yamazaki, T., Zlabinger, G. J., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200839028 · Cited by 292 · see citing works
Crispen, P. L., Sheinin, Y. M., Roth, T. J., Lohse, C. M., Kuntz, S. M., Frigola, X., Thompson, R. H., Boorjian, S. A., Dong, H., Leibovich, B. C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0536 · Cited by 272 · see citing works
Roth, T. J., Sheinin, Y., Lohse, C. M., Kuntz, S. M., Frigola, X., Inman, B. A., Krambeck, A. E., Mckenney, M. E., Karnes, R. J., Blute, M. L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1068 · Cited by 267 · see citing works
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
Zang, X., Sullivan, P. S., Soslow, R. A., Waitz, R., Reuter, V. E., Wilton, A. S., Thaler, H. T., Arul, M., Slovin, S. F., Wei, J., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.95 · Cited by 249 · see citing works
T‐cell tolerance or function is determined by combinatorial costimulatory signals
Nurieva, R., Thomas, S., Nguyen, T. D., Martín‐Orozco, N., Wang, Y., Murali‐Krishna, K., Yu, X., & Dong, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601146 · Cited by 245 · see citing works
New B7 Family Checkpoints in Human Cancers
Ni, L., & Dong, C. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0761 · Cited by 245 · see citing works
VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy
Lines, J. L., Sempere, L. F., Broughton, T., Wang, L., & Noelle, R. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0072 · Cited by 236 · see citing works
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
Peggs, K. S., Quezada, S. A., & Allison, J. P. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00649.x · Cited by 228 · see citing works
Hashiguchi, M., Kobori, H., Ritprajak, P., Kamimura, Y., Kozono, H., & Azuma, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802423105 · Cited by 225 · see citing works
The third group of the B7‐ CD 28 immune checkpoint family: HHLA 2, TMIGD 2, B7x, and B7‐H3
Janakiram, M., Shah, U. A., Liu, W., Zhao, A., Schoenberg, M., & Zang, X. (2017) · Immunological Reviews · doi:10.1111/imr.12521 · Cited by 225 · see citing works
CAR T cells for brain tumors: Lessons learned and road ahead
Akhavan, D., Alizadeh, D., Wang, D., Weist, M. R., Shepphird, J. K., & Brown, C. E. (2019) · Immunological Reviews · doi:10.1111/imr.12773 · Cited by 211 · see citing works
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Zhao, B., Li, H., Xia, Y., Wang, Y., Wang, Y., Shi, Y., Xing, H., Qu, T., Wang, Y., & Ma, W. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01364-7 · Cited by 213 · see citing works
Hofmeyer, K. A., Ray, A., & Zang, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805458105 · Cited by 203 · see citing works
BTNL2, a Butyrophilin-Like Molecule That Functions to Inhibit T Cell Activation
Nguyen, T. D., Liu, X. K., Zhang, Y., & Dong, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7354 · Cited by 194 · see citing works
Zhang, G., Hou, J., Shi, J., Yu, G., Lu, B., & Zhang, X. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02723.x · Cited by 192 · see citing works
The New B7s: Playing a Pivotal Role in Tumor Immunity
Flies, D. B., & Chen, L. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31802e085a · Cited by 188 · see citing works
Chen, X., Song, X., Li, K., & Zhang, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00292 · Cited by 177 · see citing works
Fine tuning the immune response through B7‐H3 and B7‐H4
Yi, K. H., & Chen, L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00768.x · Cited by 172 · see citing works
B7-H3 role in the immune landscape of cancer.
Castellanos, J. R., Purvis, I. J., Labak, C. M., Guda, M. R., Tsung, A. J., Velpula, K. K., & Asuthkar, S. (2017) · Europe PMC (PubMed Central) · Cited by 172 · see citing works
Clinical importance of B7-H3 expression in human pancreatic cancer
Yamato, I., Sho, M., Nomi, T., Akahori, T., Shimada, K., Hotta, K., Kanehiro, H., Konishi, N., Yagita∥, H., & Nakajima, Y. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605375 · Cited by 169 · see citing works
B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
Yonesaka, K., Haratani, K., Takamura, S., Sakai, H., Kato, R., Takegawa, N., Takahama, T., Tanaka, K., Hayashi, H., Takeda, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2852 · Cited by 167 · see citing works
Regulation of T cell activation and tolerance by PDL2
Zhang, Y., Chung, Y., Bishop, C., Daugherty, B., Chute, H. T., Holst, P. L., Kurahara, C., Lott, F. D., Sun, N., Welcher, A. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601347103 · Cited by 159 · see citing works
Sun, J., Chen, L., Zhang, G., Jiang, J., Zhu, M. L., Tan, Y. Q., Wang, H.-T., Lu, B., & Zhang, X. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0841-1 · Cited by 159 · see citing works
Scribner, J. A., Brown, J. G., Son, T., Chiechi, M., Li, P., Sharma, S., Li, H., Costa, A. D., Li, Y., Chen, Y., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0116 · Cited by 155 · see citing works
Yin–Yang of costimulation: crucial controls of immune tolerance and function
Nurieva, R. I., Liu, X., & Dong, C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00769.x · Cited by 157 · see citing works
Self-citationKang, F., Ling, W., Jia, H.-C., Li, D., Li, H., Zhang, Y., & Sun, D. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0195-z · Cited by 156 · see citing works
Miyamoto, T., Murakami, R., Hamanishi, J., Tanigaki, K., Hosoe, Y., Mise, N., Takamatsu, S., Mise, Y., Ukita, M., Taki, M., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0407 · Cited by 154 · see citing works
Aggarwal, C., Prawira, A., Antonia, S. J., Rahma, O. E., Tolcher, A. W., Cohen, R. B., Lou, Y., Hauke, R. J., Vogelzang, N. J., Zandberg, D. P., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004424 · Cited by 151 · see citing works
Loos, M., Hedderich, D. M., Ottenhausen, M., Giese, N. A., Laschinger, M., Esposito, I., Kleeff, J. H., & Friess, H. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-463 · Cited by 150 · see citing works
Not All Immune Checkpoints Are Created Equal
Linhares, A. D. S., Leitner, J. M., Grabmeier‐Pfistershammer, K., & Steinberger, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01909 · Cited by 147 · see citing works
B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis
Arigami, T., Narita, N., Mizuno, R., Nguyen, L., Ye, X., Chung, A. P., Giuliano, A. E., & Hoon, D. S. �. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181f1939d · Cited by 144 · see citing works
New checkpoints in cancer immunotherapy
Ni, L., & Dong, C. (2017) · Immunological Reviews · doi:10.1111/imr.12524 · Cited by 143 · see citing works
Novel targets for immune-checkpoint inhibition in cancer
Borgeaud, M., Sandoval, J. L., Obéid, M., Banna, G. L., Michielin, O. A., Addeo, A., & Friedlaender, A. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102614 · Cited by 147 · see citing works
Arnett, H. A., Escobar, S. M., González‐Suárez, E., Budelsky, A., Steffen, L. A., Boiani, N., Zhang, M., Siu, G., Brewer, A. W., & Viney, J. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1523 · Cited by 139 · see citing works
Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
Vigdorovich, V. I., Ramagopal, U. A., Lázár‐Molnár, E., Sylvestre, E., Lee, J. S., Hofmeyer, K. A., Zang, X., Nathenson, S. G., & Almo, S. C. (2013) · Structure · doi:10.1016/j.str.2013.03.003 · Cited by 136 · see citing works
Estriol Generates Tolerogenic Dendritic Cells In Vivo That Protect against Autoimmunity
Papenfuss, T. L., Powell, N. D., McClain, M. A., Bedarf, A., Singh, A. J., Gienapp, I. E., Shawler, T. M., & Whitacre, C. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001322 · Cited by 137 · see citing works
Mahnke, K., Ring, S., Johnson, T., Schallenberg, S., Schönfeld, K., Storn, V., Bedke, T., & Enk, A. (2007) · European Journal of Immunology · doi:10.1002/eji.200636841 · Cited by 136 · see citing works
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
Zhang, Z., Jiang, C., Liu, Z., Yang, M., Tang, X., Wang, Y., Zheng, M., Huang, J., Zhong, K., Zhao, S., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.019 · Cited by 134 · see citing works
Cai, D., Li, J., Liu, D., Hong, S., Qiao, Q., Sun, Q., Li, P., Lyu, N., Sun, T., Xie, S., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0305-2 · Cited by 133 · see citing works
Recent developments in immunotherapy for gastrointestinal tract cancers
Chong, X., Madeti, Y., Cai, J., Li, W., Cong, L., Lu, J., Mo, L., Liu, H., He, S., Yu, C., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01578-x · Cited by 129 · see citing works
B7‐H3 and Its Role in Antitumor Immunity
Loos, M., Hedderich, D. M., Friess, H., & Kleeff, J. H. (2010) · Journal of Immunology Research · doi:10.1155/2010/683875 · Cited by 117 · see citing works
Luo, L., Zhu, G., Xu, H., Yao, S., Zhou, G., Zhu, Y., Tamada, K., Huang, L., Flies, A. S., Broadwater, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130126 · Cited by 115 · see citing works
Clinical Insights Into Novel Immune Checkpoint Inhibitors
Lee, J. B., Ha, S., & Kim, H. R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.681320 · Cited by 113 · see citing works
Miyamoto, T., Murakami, R., Hamanishi, J., Tanigaki, K., Hosoe, Y., Mise, N., Takamatsu, S., Mise, Y., Ukita, M., Taki, M., et al. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.14989/doctor.k23801 · Cited by 112 · see citing works
The nature of activatory and tolerogenic dendritic cell-derived signal II
Bakdash, G., Sittig, S. P., van Dijk, T., Figdor, C. G., & de Vries, I. J. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00053 · Cited by 110 · see citing works
Histone lactylation-driven B7-H3 expression promotes tumor immune evasion
Ma, Z., Yang, J., Jia, W., Li, L., Li, Y., Hu, J., Luo, W., Li, R., Ye, D., & Lan, P. (2025) · Theranostics · doi:10.7150/thno.105947 · Cited by 113 · see citing works
Chen, C., Shen, Y., Qu, Q., Chen, X., Zhang, X., & Huang, J. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.09.006 · Cited by 105 · see citing works
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer
Guo, C. W., Figueiredo, I., Gürel, B., Neeb, A., Seed, G., Crespo, M., Carreira, S., Rekowski, J., Buroni, L., Welti, J. C., et al. (2022) · European Urology · doi:10.1016/j.eururo.2022.09.004 · Cited by 105 · see citing works
B7-H3 overexpression in pancreatic cancer promotes tumor progression
ZHAO, X., Li, D., Zhu, X., Gan, W.-J., Li, Z., XIONG, F., Zhang, Z., Zhang, G., Zhang, X., & Zhao, H. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1212 · Cited by 104 · see citing works
B7‐H3 promotes acute and chronic allograft rejection
Wang, L., Fraser, C. C., Kikly, K. K., Wells, A. D., Han, R., Coyle, A. J., Chen, L., & Hancock, W. W. (2005) · European Journal of Immunology · doi:10.1002/eji.200425518 · Cited by 102 · see citing works
Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis
Brunner, A. H., Hinterholzer, S., RISS, P. A., Heinze, G., & Brustmann, H. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.09.012 · Cited by 100 · see citing works
Schneider, T., Hoffmann, H., Dienemann, H., Schnabel, P. A., Enk, A., Ring, S., & Mahnke, K. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31821c421d · Cited by 98 · see citing works
Li, Y., Huang, J., Foley, N. M., Xu, Y., Li, Y. P., Pan, J., Redmond, H. P., Wang, J. H., & Wang, J. (2016) · Scientific Reports · doi:10.1038/srep31284 · Cited by 98 · see citing works
Bolandi, N., Derakhshani, A., Hemmat, N., Baghbanzadeh, A., Asadzadeh, Z., Nour, M. A., Brunetti, O., Bernardini, R., Silvestris, N., & Baradaran, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910719 · Cited by 96 · see citing works
Costimulation, Coinhibition and Cancer
Inman, B. A., Frigola, X., Dong, H., & Kwon, E. D. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006878 · Cited by 96 · see citing works
B7-H3 Augments the Inflammatory Response and Is Associated with Human Sepsis
Zhang, G., Wang, J., Kelly, J., Gu, G., Hou, J., Zhou, Y., Redmond, H. P., Wang, J. H., & Zhang, X. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904020 · Cited by 94 · see citing works
The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy
Leung, J., & Suh, W. (2014) · Immune Network · doi:10.4110/in.2014.14.6.265 · Cited by 92 · see citing works
B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
Yuan, H., Wei, X., Zhang, G., Li, C., Zhang, X., & Hou, J. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.04.103 · Cited by 89 · see citing works
Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment
Ziogas, D. C., Theocharopoulos, C., Lialios, P., Foteinou, D., Koumprentziotis, I., Xynos, G., & Gogas, H. J. (2023) · Cancers · doi:10.3390/cancers15102718 · Cited by 92 · see citing works
Molecular mechanisms of T‐cell tolerance
Nurieva, R., Liu, X., & Dong, C. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01012.x · Cited by 88 · see citing works
Diagnosis value of serum B7-H3 expression in non-small cell lung cancer
Zhang, G., Xu, Y., Lü, X., Huang, H., Zhou, Y., Lu, B., & Zhang, X. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.01.017 · Cited by 89 · see citing works
Petroff, M. G., Kharatyan, E., Torry, D. S., & Holets, L. M. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62990-2 · Cited by 86 · see citing works
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
Russell, B. L., Sooklal, S. A., Malindisa, S. T., Daka, L. J., & Ntwasa, M. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.641428 · Cited by 84 · see citing works
Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases
Chavin, G., Sheinin, Y. M., Crispen, P. L., Boorjian, S. A., Roth, T. J., Rangel, L. J., Blute, M. L., Sebo, T. J., Tindall, D., Kwon, E. D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2262 · Cited by 82 · see citing works
Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
Archilla‐Ortega, A., Domuro, C., Martín-Liberal, J., & Muñoz, P. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02264-x · Cited by 79 · see citing works
Li, H., Yang, Z., & Guo, Q. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00789-w · Cited by 81 · see citing works
Veenstra, R. G., Flynn, R. P., Kreymborg, K. G., McDonald-Hyman, C. S., Saha, A., Taylor, P. A., Osborn, M. J., Panoskaltsis‐Mortari, A., Schmitt-Graeff, A. H., Lieberknecht, E., et al. (2015) · Blood · doi:10.1182/blood-2014-09-603357 · Cited by 77 · see citing works
Generation and Characterization of B7-H4/B7S1/B7x-Deficient Mice
Suh, W., Wang, S., Duncan, G. S., Miyazaki, Y., Cates, E. C., Walker, T. D., Gajewska, B., Deenick, E. K., Dawicki, W., Okada, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00755-06 · Cited by 76 · see citing works
Shi, W. M., Wang, Y., Zhao, Y., Kim, J. J., Li, H., Meng, C., Chen, F., Zhang, J., Mak, D. H. F., Van, V., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf6724 · Cited by 78 · see citing works
Xiong, G., Chen, Z., Liu, Q., Peng, F., Zhang, C., Cheng, M., Ling, R., Chen, S., Liang, Y., Chen, D., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008662 · Cited by 74 · see citing works
Vasaturo, A., Blasio, S. D., Peeters, D. G. A., de Koning, C. C. H., de Vries, I. J. M., Figdor, C. G., & Hato, S. V. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00417 · Cited by 72 · see citing works
Emerging Immunotherapy for Acute Myeloid Leukemia
Tabata, R., Chi, S., Yuda, J., & Minami, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041944 · Cited by 72 · see citing works
Regulation of costimulation in the era of butyrophilins
Arnett, H. A., Escobar, S. M., & Viney, J. L. (2009) · Cytokine · doi:10.1016/j.cyto.2009.03.009 · Cited by 71 · see citing works
An Orthotopic Colon Cancer Model for Studying the B7-H3 Antitumor Effect In Vivo
Lupu, C., Eisenbach, C., Kuefner, M. A., Schmidt, J., Lupu, A., Stremmel, W., & Encke, J. (2006) · Journal of Gastrointestinal Surgery · doi:10.1007/bf03239969 · Cited by 68 · see citing works
REVIEW ARTICLE: B7 Family Molecules as Regulators of the Maternal Immune System in Pregnancy
Petroff, M. G., & Perchellet, A. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00841.x · Cited by 67 · see citing works
Tran, C. N., Thacker, S. G., Louie, D. M., Oliver, J. A., White, P. T., Endres, J., Urquhart, A. G., Chung, K. C., & Fox, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2989 · Cited by 66 · see citing works
Ring, S., Maas, M., Nettelbeck, D. M., Enk, A., & Mahnke, K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202592 · Cited by 66 · see citing works
Yim, J., Koh, J., Kim, S., Song, S. G., Ahn, H. K., Kim, Y. A., Jeon, Y. K., & Chung, D. H. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.03.033 · Cited by 67 · see citing works
Peuker, K., Strigli, A., Tauriello, D. V. F., Hendricks, A., Schönfels, W. V., Burmeister, G., Brosch, M., Herrmann, A., Krüger, S., Nitsche, J., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.03.008 · Cited by 64 · see citing works
The Role of Coinhibitory Signaling Pathways in Transplantation and Tolerance
McGrath, M. M., & Najafian, N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00047 · Cited by 62 · see citing works
B7-H3 expression in ductal and lobular breast cancer and its association with IL-10
Liu, C., Liu, J., Wang, J., Liu, Y., Zhang, F., LIN, W., Gao, A., Sun, M., Wang, Y., & Sun, Y. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1158 · Cited by 63 · see citing works
Ma, L., Luo, L., Qiao, H., Dong, X., Pan, S., Jiang, H., Krissansen, G. W., & Sun, X. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.031 · Cited by 61 · see citing works
- Authors
- Prasad, D. V. R., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y., & Dong, C.
- Affiliations
- University of Washington (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08
- Volume
- 173
- Issue
- 4
- Pages
- 2500-2506
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2110172571
- Cited by
- 368
- References
- 42
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 30 · 2023: 22 · 2022: 27 · 2021: 34 · 2020: 27 · 2019: 18 · 2018: 10 · 2017: 16 · 2016: 11 · 2015: 11 · 2014: 6 · 2013: 14 · 2012: 17
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- B7-H3, T cell activation, dendritic cells, professional antigen-presenting cells, IFN-gamma production, experimental autoimmune encephalomyelitis, T cell proliferation, mice
- MeSH terms
- Animals, Antigen-Presenting Cells, B-Lymphocytes, Cells, Cultured, Dendritic Cells, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Lymphocyte Activation, Macrophages, T-Lymphocytes, Cytokines, B7-1 Antigen, Antibodies, Blocking, Mice, Rats, B7 Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
